Improving pediatric familial hypercholesterolemia diagnosis by looking deeper into families
- PMID: 37839935
- DOI: 10.1016/j.atherosclerosis.2023.117317
Improving pediatric familial hypercholesterolemia diagnosis by looking deeper into families
Keywords: Aatherosclerosis; Cholesterol; Genetics; Xanthomas.
Conflict of interest statement
Declaration of competing interest Dr. Santos reports receiving the following: consulting fees and lecture fees from Abbott, Amgen, Amryt, AstraZeneca, Aché, Biolab, Eli Lilly, Libbs, PTC Therapeutics, Novo Nordisk, Novartis, Sanofi-Regeneron Pharmaceuticals; grant support from Amgen, Kowa, Esperion, Novartis, Sanofi/Regeneron Pharmaceuticals.
Comment on
-
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study.Atherosclerosis. 2023 Nov;385:117231. doi: 10.1016/j.atherosclerosis.2023.117231. Epub 2023 Aug 12. Atherosclerosis. 2023. PMID: 37648636
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical